Articles Archives - Page 107 of 714

TuesdayFeb 13, 2024 9:45 am

GEMXX Corp. (GEMZ) Anticipates Significant Growth over the Next 24 Months on ‘Tremendous Potential’ in Ammolite and Gold Markets

GEMXX expects the growing demand for Ammolite, coupled with the positive outlook for gold prices, to support significant growth over the next 24 months Last year, GEMXX moved to complement its Ammolite operations with the purchase of gold assets in Canada The price of gold has held steady above US$2,000 per ounce, coming off a record-breaking 2023 when it rallied to a record-high year-end close The future looks promising for gold because it is projected to reach new highs in the coming months, according to GEMXX The price of an ounce of gold rallied to a record high year-end close…

TuesdayFeb 13, 2024 9:00 am

Clene Inc. (NASDAQ: CLNN) Revolutionizes Approach to Restore Neuronal Health in Neurodegenerative Disease with CNM-Au8(R)

Neurodegenerative diseases pose a significant challenge in healthcare, yet treatment options remain limited CNM-Au8(R) has demonstrated remarkable efficacy across various nervous system cell types, with its ability to target fundamental deficiencies associated with dying neurons Gold nanocrystals found in CNM-Au8 act as miniature mitochondria, providing neurons with much-needed ATP energy while simultaneously converting toxic reactive oxygen species into harmless compounds Neurodegenerative diseases pose a significant challenge in healthcare, yet treatment options remain limited. Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, is working on a potentially groundbreaking…

MondayFeb 12, 2024 10:30 am

Sustain SoCal Sustainable Agriculture and Food Systems 2024 – Presents Latest Ag and Food Systems Developments

Sustain SoCal invites regional leaders, regulatory authorities, individuals, and entities in the food and agriculture spectrum, to gather at the Sustainable Agriculture and Food Systems Event on February 20, 2024, and share their journeys, achievements, failures, and shortfalls in the existing system. With seven years in the agricultural space, the event will be attended by top industry leaders, entrepreneurs, and investors in Southern California. For companies looking to maximize their visibility in a crowd of agriculture and food leaders, this Sustain SoCal event offers the perfect avenue. A variety of packages are available to fit every company’s needs that would…

MondayFeb 12, 2024 9:45 am

SOBRsafe Inc. (NASDAQ: SOBR) Announces SOBRsure(TM) Sales Activities in Australia and New Zealand

SOBRsure sales activities in Australia and New Zealand have been initiated through an international channel partnership with Drug Testing Business Success Drug Testing Business Success has a 14-year history representing the world's most widely-used ankle bracelet for alcohol detection The global alcohol sensor market was valued at $2.3 billion in 2022, and is expected to reach $6.3 billion by 2030 SOBRsafe's products are geared toward behavioral health, justice, and consumer markets – and well-positioned for licensing and integration SOBRsafe (NASDAQ: SOBR), a provider of next-generation transdermal alcohol detection solutions, recently announced that it has initiated SOBRsure(TM) sales activities in Australia…

MondayFeb 12, 2024 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) CEO, Chris Bunka, Shares 2023 Company Update and 2024 Roadmap in Annual Letter

Lexaria, a global innovator in drug delivery platforms, just announced ambitious plans for the 2024 calendar year The letter confirms that the 2024 plans have been made possible by significant strides that were made by the company in 2023 Lexaria looks to build on the momentum gained from the previous year, ultimately asserting market dominance and making 2024 its best year yet Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its ambitious plans for the 2024 calendar year. In his annual letter, Chris Bunka, Lexaria’s CEO, noted that this would mark the year that will…

FridayFeb 09, 2024 10:30 am

China Rare Earths ‘Crisis’ Spells BIG Opportunity

We’ve known this was coming, for a very long time. For well over a decade, various experts have been warning governments and industry about global over-reliance on China for the supply of rare earth elements (REE). Now, this day of reckoning has arrived. Beginning in the spring of 2023, China first “threatened” to impose restrictions on the export of some rare earths. Just recently, China passed a law that could reduce its exports of critical REE. However, you don’t have to be Chinese to see “crisis” and “opportunity” as being two sides of the same coin. Fortunately, a number of…

FridayFeb 09, 2024 9:00 am

Electronic Servitor Publication Network Inc. (XESP) Combines Powerful Digital Engagement Engine(TM) with Simple Pricing Model to Drive Growth of Client Companies

Electronic Servitor Publication Network provides the Digital Engagement Engine(TM), a sophisticated technology stack that helps businesses fully engage target audiences more efficiently, moving audiences from awareness to action, thereby driving growth The Digital Engagement Engine(TM) is digitally transforming content marketing by solving deficiencies through a higher level of sophisticated automation The technology offers numerous benefits, including enabling client companies to target their leads with greater accuracy, dynamically delivering provisioned content, and heightening the effectiveness of content marketing XESP uses a pricing model that lowers the barrier to entry, allowing more customers to harness the benefits of its superior technology stack…

ThursdayFeb 08, 2024 9:00 am

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Is ‘One to Watch’

In December 2023, Fathom Nickel launched a non-brokered private placement to accredited investors for proceeds of C$4.5 million In September 2023, Fathom drilled seven drillholes at the Gochager Lake project as a follow-up program to two drillholes drilled in February 2023; as of the end of 2023, Fathom drilled nine holes at the project amounting to ~2,800 meters Fathom Nickel in June 2023 announced completion of a non-brokered private placement to accredited investors for proceeds of C$3 million The company in June 2023 commenced geophysical survey programs at its Albert Lake and Gochager Lake nickel projects Fathom Nickel in September…

WednesdayFeb 07, 2024 9:45 am

Correlate Energy Corp. (CIPI) Riding the Energy Transition Wave as More Companies in the U.S. Move to Electrification

Correlate Energy, a publicly traded distributed energy solutions company, is looking to position itself as the go-to company as America continues transitioning to renewables and electrification With the USPS announcing a $40 billion investment strategy to upgrade and improve its operations, including a major addition of EVs and charging stations, other players are following suit Through its three-pronged strategy – sell, retain, and acquire – Correlate anticipates a spike in demand for its products and services that offer companies a strong economic motivation to enhance energy efficiency Correlate Energy (OTCQB: CIPI), a publicly traded company is capitalizing on America’s growing…

WednesdayFeb 07, 2024 9:00 am

Longeveron Inc.’s (NASDAQ: LGVN) Long-Term Follow-Up Data from Its ELPIS I Clinical Trial Presented at the 2023 Annual Scientific Sessions of the American Heart Association

A poster about Longeveron’s long-term follow-up data from its ELPIS I clinical trial was presented at the 2023 Scientific Sessions of the American Heart Association in November 2023 The poster showed that 100% of the 10 patients enrolled in the study survived and remained heart transplant-free for up to 5 years of age after receiving Lomecel-B(TM) during their Stage II surgery The data supports Longeveron’s ongoing ELPIS II study, which has exceeded its 50% enrollment threshold The company believes the long-term follow-up data underscore the potential for Lomecel-B(TM) as a much-needed therapeutic innovation for HLHS patients Historical results from outside…

Site Search

Company Search

Category: Articles